Interleukin-6 treatment augments cutaneous wound healing in immunosuppressed mice
- PMID: 11559438
- DOI: 10.1089/10799900152547867
Interleukin-6 treatment augments cutaneous wound healing in immunosuppressed mice
Abstract
It has been postulated that the inflammatory response that occurs after cutaneous wounding is a prerequisite for healing and that inflammatory cytokines, such as interleukin-6 (IL-6) are involved in this process. We showed previously that IL-6-deficient mice display delayed wound healing, which could be reversed by administration of a murine IL-6 expression plasmid or recombinant murine IL-6 (rMuIL-6). In the present study, we observed that delayed cutaneous wound healing, which occurs as a result of glucocorticoid-induced immunosuppression, can also be reversed by rMuIL-6, as evidenced by epithelialization, granulation tissue formation, and wound closure. In vehicle control mice, rMuIL-6 did not augment healing but rather delayed the process. Immunochemical studies indicated that the expression of matrix metalloproteinase-10 (MMP-10) was increased in dexamethasone-treated mice and that rMuIL-6 treatment reduced its expression, indicating that IL-6 may influence dermal matrix formation and, specifically, collagen synthesis. These results demonstrate that IL-6 can restore abnormal wound repair that occurs in immunodeficiency and suggest its use as a potential therapy.
Similar articles
-
Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice.FASEB J. 2000 Dec;14(15):2525-31. doi: 10.1096/fj.00-0073com. FASEB J. 2000. PMID: 11099471
-
Oleic acid modulation of the immune response in wound healing: a new approach for skin repair.Immunobiology. 2011 Mar;216(3):409-15. doi: 10.1016/j.imbio.2010.06.007. Epub 2010 Jul 23. Immunobiology. 2011. PMID: 20655616
-
Wound healing mediator production by human dermal fibroblasts grown within a collagen-GAG matrix for skin repair in humans.Eur Cytokine Netw. 2003 Jan-Mar;14(1):60-4. Eur Cytokine Netw. 2003. PMID: 12799215
-
Interleukin-6 and the skin.Int Arch Allergy Immunol. 1996 Apr;109(4):308-17. doi: 10.1159/000237257. Int Arch Allergy Immunol. 1996. PMID: 8634514 Review.
-
Wound repair at a glance.J Cell Sci. 2009 Sep 15;122(Pt 18):3209-13. doi: 10.1242/jcs.031187. J Cell Sci. 2009. PMID: 19726630 Free PMC article. Review. No abstract available.
Cited by
-
Interleukin (IL)-6 modulates transforming growth factor-beta expression in skin and dermal fibroblasts from IL-6-deficient mice.Br J Dermatol. 2009 Aug;161(2):237-48. doi: 10.1111/j.1365-2133.2009.09215.x. Epub 2009 Apr 29. Br J Dermatol. 2009. PMID: 19438433 Free PMC article.
-
Monocyte Chemotactic Protein-1-Interleukin-6-Osteopontin Pathway of Intra-Aneurysmal Tissue Healing.Stroke. 2017 Apr;48(4):1052-1060. doi: 10.1161/STROKEAHA.116.015590. Epub 2017 Mar 14. Stroke. 2017. PMID: 28292871 Free PMC article.
-
Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages.Exp Hematol. 2009 Dec;37(12):1445-53. doi: 10.1016/j.exphem.2009.09.004. Epub 2009 Sep 20. Exp Hematol. 2009. PMID: 19772890 Free PMC article.
-
Chemical Characterization and Wound Healing Property of Jacaranda decurrens Cham. (Bignoniaceae): An Experimental Study Based on Molecular Mechanisms.Evid Based Complement Alternat Med. 2020 Apr 20;2020:4749712. doi: 10.1155/2020/4749712. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32382292 Free PMC article.
-
Proliferation of Ly6C+ monocytes/macrophages contributes to their accumulation in mouse skin wounds.J Leukoc Biol. 2020 Apr;107(4):551-560. doi: 10.1002/JLB.3HI1119-389RRRR. Epub 2019 Nov 28. J Leukoc Biol. 2020. PMID: 31777992 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources